Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Bariatric surgery helps with weight loss but can cause physical and mental health challenges.

Diabetes may lower the risk of prostate cancer.

Purple corn extract may help reduce prostate enlargement and inflammation.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Krill oil may help reduce prostate enlargement and growth.

Frailer men have a higher risk of worsening prostate problems and serious health events needing hospital care.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.